This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Shandong University, Tsingtao A-Smart Medical Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Innovations by Hongbin Liu in Ovarian Treatment
Introduction
Hongbin Liu is a notable inventor based in Shandong, China. He has made significant contributions to the field of reproductive health through his innovative methods and research. His work focuses on enhancing the developmental and reproductive potential of mammalian ovaries.
Latest Patents
Hongbin Liu holds a patent for a method titled "Method for activating follicles by means of using small-molecule compound." This patent discloses a method and culture medium for performing in vivo treatment on ovaries of mammals, including humans, or for conducting in vitro culturing on ex vivo ovaries or ovarian tissue using 4-vinylcyclohexene diepoxide. The method facilitates the retention and enhancement of the developmental and reproductive potential of mammalian ovaries or ovarian tissue. It is particularly effective in promoting follicle maturation and increasing the number of ovulations.
Career Highlights
Throughout his career, Hongbin Liu has worked with reputable organizations, including Tsingtao A-Smart Medical Technology Co., Ltd. and Shandong University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hongbin Liu has collaborated with esteemed colleagues such as Jinlong Ma and Lianbao Cao. These partnerships have further enriched his research endeavors and have led to significant advancements in the field.
Conclusion
Hongbin Liu's innovative work in ovarian treatment showcases his dedication to improving reproductive health. His patent and collaborations highlight his contributions to the scientific community and the potential impact of his research on future medical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile